,,I assume the biotech world on both sides of the border sees the other company as some what of a comedy skit. The poor business model, the lack of progress and the number of failures on record probably is more visible and preceeds his every move in the information arena. We have covered the globe presenting the science only to see inaction at the traders level. It will be a complete accident if considerable value comes to either of these entities...she be rudderless for the most part and forward movement is being performed by 3rd parties,,,,,not to say,,lack of funding all around keeps us in desperation,,,even offering up our soul when financing with loan sharking groups,,,,,jmo